Alpa Laboratories Balance Sheet Health
Financial Health criteria checks 6/6
Alpa Laboratories has a total shareholder equity of ₹1.4B and total debt of ₹15.6M, which brings its debt-to-equity ratio to 1.1%. Its total assets and total liabilities are ₹1.8B and ₹405.8M respectively. Alpa Laboratories's EBIT is ₹123.8M making its interest coverage ratio -9.7. It has cash and short-term investments of ₹1.0B.
Key information
1.1%
Debt to equity ratio
₹15.61m
Debt
| Interest coverage ratio | -9.7x |
| Cash | ₹1.02b |
| Equity | ₹1.43b |
| Total liabilities | ₹405.85m |
| Total assets | ₹1.84b |
Recent financial health updates
Recent updates
Here's Why We Think Alpa Laboratories (NSE:ALPA) Might Deserve Your Attention Today
Dec 14
Shareholders May Not Be So Generous With Alpa Laboratories Limited's (NSE:ALPA) CEO Compensation And Here's Why
Sep 23Here's Why Alpa Laboratories (NSE:ALPA) Has Caught The Eye Of Investors
Aug 26Is Alpa Laboratories (NSE:ALPA) A Risky Investment?
Jan 19Is Now The Time To Put Alpa Laboratories (NSE:ALPA) On Your Watchlist?
Jun 17If You Like EPS Growth Then Check Out Alpa Laboratories (NSE:ALPA) Before It's Too Late
Feb 23Alpa Laboratories' (NSE:ALPA) Earnings Aren't As Good As They Appear
Nov 24Here's Why I Think Alpa Laboratories (NSE:ALPA) Might Deserve Your Attention Today
Oct 05Do Alpa Laboratories's (NSE:ALPA) Earnings Warrant Your Attention?
May 31With EPS Growth And More, Alpa Laboratories (NSE:ALPA) Is Interesting
Jan 28Financial Position Analysis
Short Term Liabilities: ALPA's short term assets (₹1.7B) exceed its short term liabilities (₹383.0M).
Long Term Liabilities: ALPA's short term assets (₹1.7B) exceed its long term liabilities (₹22.8M).
Debt to Equity History and Analysis
Debt Level: ALPA has more cash than its total debt.
Reducing Debt: ALPA's debt to equity ratio has reduced from 2.8% to 1.1% over the past 5 years.
Debt Coverage: ALPA's debt is well covered by operating cash flow (2387.5%).
Interest Coverage: ALPA earns more interest than it pays, so coverage of interest payments is not a concern.